Stocks
Mutual Funds
ETFs
Pro Tools
Terminal
WealthView
Pricing
Learn More
stocksGENPHARMA
resources
GENPHARMA

Genpharmasec Ltd.

BSE: 531592
Sector: Services
1.02+0.0 (+0.99%)
26 Aug, 12:00 AM

Annual Reports and Financial Documents

Genpharmasec Ltd. annual reports, quarterly results, earnings call transcripts and investor presentations. All official filings in one place.
20132014201520162017201820192020202120222023202420252026
Annual ReportsFY 2013FY 2014FY 2015FY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025—
Quarterly Results—————
Conference Calls——————————————
Presentations——————————————

Corporate Announcements and Regulatory Filings

Genpharmasec Ltd. BSE/NSE disclosures, board meeting outcomes, insider trading notifications, acquisitions and other regulatory filings.
  1. Press Release / Media Release13 Aug 2026
    Announcement under Regulation 30 (LODR)-Press Release / Media Release
    Regarding Recent Agreement with Amneal Healthcare Private Limited
  2. Newspaper Publication13 Aug 2026
    Announcement under Regulation 30 (LODR)-Newspaper Publication
    Newspaper Publication of Unaudited Financial Results for the quarter ended 30th June, 2026.
  3. Reg. 32 (1), (3) - Statement of Deviation & Variation11 Aug 2026
    Statement Of Deviation Or Variation In The Use Of Proceeds Of Rights Issue For The Quarter Ended 30Th June, 2026.
    Statement of deviation or variation in the use of proceeds of Rights Issue for the Quarter ended 30th June, 2026.
  4. Outcome of Board Meeting11 Aug 2026
    Board Meeting Outcome for Outcome Of The Meeting Of Board Of Directors Held On Tuesday, 11Th August, 2026.
    Outcome of the Meeting of Board of Directors held on Tuesday, 11th August, 2026.
  5. Board Meeting3 Aug 2026
    Board Meeting Intimation for Intimation Of Board Meeting To Be Held On Tuesday, 11Th August, 2026.
    Genpharmasec Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2026 ,inter alia, to consider and approve 1. To consider and approve Un-audited ....
  6. Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 20187 Jul 2026
    Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
    Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulation, 2018 for the quarter ended June 30, 2026.
  7. Closure of Trading Window26 Jun 2026
    Closure of Trading Window
    Intimation of Closure of Trading Window
  8. Reg.24(A)-Annual Secretarial Compliance27 May 2026
    Compliances-Reg.24(A)-Annual Secretarial Compliance
    Annual Secretarial Compliance Report for the year ended March 31, 2026.
  9. Newspaper Publication23 May 2026
    Announcement under Regulation 30 (LODR)-Newspaper Publication
    Newspaper Publication of Audited Financial Result for the quarter and year ended 31st March, 2026.
  10. Reg. 32 (1), (3) - Statement of Deviation & Variation21 May 2026
    Statement Of Deviation Or Variation In The Use Of Proceeds Of Rights Issue For The Quarter Ended 31St March, 2026.
    Statement of deviation or variation in the use of proceeds of Rights issue for the Quarter ended 31st March, 2026.
  11. Outcome of Board Meeting21 May 2026
    Board Meeting Outcome for Outcome Of The Meeting Of Board Of Directors Held On Thursday, May 21, 2026.
    Outcome of the Meeting of Board of Directors held on Thursday, May 21, 2026.
  12. Board Meeting13 May 2026
    Board Meeting Intimation for Intimation Of Board Meeting To Be Held On Thursday, 21St May, 2026.
    Genpharmasec Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 21/05/2026 ,inter alia, to consider and approve 1. To consider, approve & take ....
  13. Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A14 Apr 2026
    Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
    <b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=''1px''><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> ....
  14. Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 20188 Apr 2026
    Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
    Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulation, 2018 for the quarter ended March 31, 2026.
  15. Closure of Trading Window26 Mar 2026
    Closure of Trading Window
    Intimation of closure of Trading window.
  16. General24 Mar 2026
    Outcome Of Separate Meeting Of Independent Directors Of The Company.
    Outcome of Separate Meeting of Independent Directors held on March 24, 2026.
  17. Newspaper Publication11 Feb 2026
    Announcement under Regulation 30 (LODR)-Newspaper Publication
    Newspaper Publication of Unaudited Financial Result for the quarter ended December 31, 2025.
  18. Reg. 32 (1), (3) - Statement of Deviation & Variation9 Feb 2026
    Statement Of Deviation Or Variation In The Use Of Proceeds Of Rights Issue For The Quarter Ended 31St December, 2025.
    Statement of deviation or variation in the use of proceeds of Rights issue for the Quarter ended 31st December, 2025.
  19. Outcome of Board Meeting9 Feb 2026
    Board Meeting Outcome for Outcome Of The Meeting Of Board Of Directors Held On Monday, February 09, 2026.
    Outcome of the Meeting of Board of Directors held on Monday, February 09, 2026.
  20. Board Meeting2 Feb 2026
    Board Meeting Intimation for Intimation Of Board Meeting To Be Held On Monday, 09Th February, 2026.
    Genpharmasec Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/02/2026 ,inter alia, to consider and approve 1. To consider and approve Unaudited ....

Frequently Asked Questions

Where can I download the annual report of Genpharmasec Ltd.?
Annual reports of Genpharmasec Ltd. are available for download in the Annual Reports and Financial Documents section of the Resources tab, organised by financial year.
Where can I find the quarterly results of Genpharmasec Ltd.?
Quarterly earnings results and presentations of Genpharmasec Ltd. are available in the Annual Reports and Financial Documents section of the Resources tab. Detailed financials are also in the Statements tab.
Does Genpharmasec Ltd. publish earnings call transcripts?
Earnings call transcripts of Genpharmasec Ltd., where available, are listed in the Annual Reports and Financial Documents section of the Resources tab.
Where can I find investor presentations of Genpharmasec Ltd.?
Investor presentations and annual day presentations of Genpharmasec Ltd. are listed in the Resources tab under Annual Reports and Financial Documents.
What are the recent corporate announcements of Genpharmasec Ltd.?
Corporate announcements and regulatory filings of Genpharmasec Ltd. as submitted to BSE and NSE are available in the Corporate Announcements and Regulatory Filings section of the Resources tab.
How do I access the regulatory filings of Genpharmasec Ltd.?
Regulatory filings including board meeting outcomes, insider trading disclosures and other exchange notifications of Genpharmasec Ltd. are in the Corporate Announcements and Regulatory Filings section of the Resources tab.
What is the ISIN of Genpharmasec Ltd.?
The ISIN (International Securities Identification Number) of Genpharmasec Ltd. is INE861N01036. This is the unique identifier used across exchanges and depositories.
On which stock exchange is Genpharmasec Ltd. listed?
Genpharmasec Ltd. is listed on NSE and BSE. The NSE symbol is GENPHARMA and the BSE code is -.
Where can I find the shareholding pattern of Genpharmasec Ltd.?
The quarterly shareholding pattern of Genpharmasec Ltd. showing promoter, FII, DII, mutual fund and public holdings is available in the Shareholding Pattern section on the Overview tab.
How current is the data for Genpharmasec Ltd. on Sharpely?
Share price data for Genpharmasec Ltd. is updated as of 26 Aug 2026. Financial statements, shareholding and other fundamental data are updated after each quarterly disclosure.